Savitri Singh Thyrocare

PROCESSED AT :
Thyrocare
D-37/1,TTC MIDC,Turbhe,
Navi Mumbai-400 703
NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

REF. BY OPP. ST ANTHONY SCHOOL COURT ROAD CIVIL
: DR AMIT SRIVASTAVA
LINES BARABANKI, UTTAR PRADESH - 225001
TEST ASKED : ELEMENTS 22 (TOXIC AND
NUTRIENTS),HbA1c,HEMOGRAM
PATIENTID : SS17165886
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC - NGSP Certified)
H.P.L.C 5.7 %
Reference Range :
Reference Range: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C. using Biorad Variant II Turbo
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 117 mg/dl
Reference Range :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 05 Jul 2021 09:10
Sample Received on (SRT) : 06 Jul 2021 01:16

Report Released on (RRT) : 06 Jul 2021 05:00
Sample Type : EDTA
Labcode : 0507091650/UP172 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode : T3121856
Page : 1 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

REF. BY : DR AMIT SRIVASTAVA OPP. ST ANTHONY SCHOOL COURT ROAD CIVIL
TEST NAME VALUE UNITS REFERENCE RANGE
TOTAL LEUCOCYTES COUNT 4.69 X 10³ / µL 4.0-10.0
NEUTROPHILS 65.4 % 40-80
LYMPHOCYTE PERCENTAGE 27.9 % 20.0-40.0
MONOCYTES 3.4 % 0.0-10.0
EOSINOPHILS 2.8 % 0.0-6.0
BASOPHILS 0.2 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT 3.07 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 1.31 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.16 X 10³ / µL 0.2-1.0
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0.02-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.13 X 10³ / µL 0.02-0.5
IMMATURE GRANULOCYTES(IG) 0.01 X 10³ / µL 0.0-0.3
TOTAL RBC 4.35 X 10^6/µL 3.9-4.8
NUCLEATED RED BLOOD CELLS Nil X 10³ / µL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 11.4 g/dL 12.0-15.0
HEMATOCRIT(PCV) 38.3 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) 88 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 26.2 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 29.8 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 52 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 16 % 11.6-14.0
PLATELET COUNT 152 X 10³ / µL 150-400
Please Correlate with clinical conditions.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow
Cytometry Method (using a semiconductor laser), and SLS- hemoglobin method)

Sample Type : EDTA
Barcode : T3121856 Page : 2 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

REF. BY OPP. ST ANTHONY SCHOOL COURT ROAD CIVIL LINES
BARABANKI, UTTAR PRADESH - 225001
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
ARSENIC ICP-MS 0.62 µg/l <5
CADMIUM ICP-MS 0.79 µg/l < 1.5
MERCURY ICP-MS 0.33 µg/l <5
LEAD ICP-MS 31.94 µg/l < 150
CHROMIUM ICP-MS 0.74 µg/l < 30
BARIUM ICP-MS 1.6 µg/l < 30
COBALT ICP-MS 0.24 µg/l 0.10 - 1.50
CAESIUM ICP-MS 2.05 µg/l <5
THALLIUM ICP-MS 0.03 µg/l <1
URANIUM ICP-MS 0.05 µg/l <1
STRONTIUM ICP-MS 18.86 µg/l 8 - 38
ANTIMONY ICP-MS 6.78 µg/l 0.10 - 18
TIN ICP-MS 0.15 µg/l <2
MOLYBDENUM ICP-MS 1.07 µg/l 0.70 - 4.0
SILVER ICP-MS 0.67 µg/l <4
VANADIUM ICP-MS 0.47 µg/l < 0.8
BERYLLIUM ICP-MS 0.03 µg/l 0.10 - 0.80
BISMUTH ICP-MS 0.2 µg/l 0.10 - 0.80
SELENIUM ICP-MS 158.1 µg/l 60 - 340
ALUMINIUM ICP-MS 3.79 µg/l < 30
NICKEL ICP-MS 1.34 µg/l < 15
MANGANESE ICP-MS 13.58 µg/l 7.10 - 20
Method :
ICP - MASS SPECTROMETRY
Note:Reference range has been obtained after considering 95% population as cutoff.

Sample Type : EDTA
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

TEST ASKED : AAROGYAM 1.3
CYSTATIN C IMMUNOTURBIDIMETRY 1.2 mg/L
Reference Range :-
<= 60 years: <= 1.03 mg/L

> 60 years : < 1.50 mg/L
Clinical significance
Cystatin c, is a small 13-kda protein and is a member of the cysteine proteinase inhibitor family, it is produced at a constant rate by all
nucleated cells. Due to its small size it is freely filtered by the glomerulus and is not secreted but is fully reabsorbed and broken down
by the renal tubules. This means that the primary determinate of blood Cystatin c levels is the rate at which it is filtered at the
glomerulus making it an excellent gfr marker. Cystatin c is also a marker of inflammation and like many other markers of
inflammation; its serum concentration may be higher in patients with decreased renal clearance. There is mounting evidence, however,
that Cystatin c may be a predictor of adverse outcomes independent of renal function with its higher sensitivity to detect a reduced
GFR than Creatinine determination, also in the so-called “Creatinine-blind” range. Thus, Cystatin c is suggested to be a better marker
for GFR than the ubiquitous serum Creatinine.
Reference
1. Barrett aj, Davies me, Grubb a. the place of human gamma-trace (Cystatin c) among the cysteine proteinase inhibitors. Biochem
biophys res common 1984; 120: 631-6.
2. Grubb a. diagnostic value of analysis of Cystatin c and protein HC in biological fluids. Clin Nephrol 1992; 38: S20-7.
Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

HOMOCYSTEINE C.L.I.A 21.5 µmol/L
Reference Range :-
< 30
Clinical Significance:
Homocysteine is linked to increased risk of premature coronary artery disease, stroke and thromboembolism. Moreover, alzheimer’s
disease, osteoporosis, venous thrombosis, schizophrenia, cognitive deficiency and pregnancy complications also elevates Homocysteine
levels.
High Values:
Elevated homocysteine levels might be due to increasing age, genetic traits, drugs, renal dysfunction and dietary deficiency of vitamins
or smoking. To lower your homocysteine, eat more green vegetables, stop smoking, alcohol. Folic acid helps lowering elevated levels.
Method:- FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

25-OH VITAMIN D (TOTAL) C.L.I.A 12.63 ng/ml

Reference Range :
DEFICIENCY : <20 ng/ml
INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml
TOXICITY : >100 ng/ml
Vitamin D Total test is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per Vitamin D Standardization
Program (VDSP).
Specifications: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml

Method : FULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY
VITAMIN B-12 C.L.I.A 145 pg/ml
Reference Range :
Normal : 211 - 911 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml
External quality control program participation:

College of American pathologists: ligand assay (general) survey; CAP number: 7193855-01
Kit validation references:

Chen IW,Sperling MI,Heminger IA.Vitamin B12.In:Pesce AJ,Kalpan LA,editors.Methods in clinical chemistry. St.Louis:CV
Mosby,1987.P.569-73.
Method : FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Barcode : T3885340
Page : 6 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 150 mg/dL

Reference Range :
MALE : 86 - 152
FEMALE : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 114 mg/dL
Reference Range :
MALE : 56 - 145
FEMALE : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio
Reference Range :
MALE : 0.40 - 1.26
FEMALE : 0.38 - 1.14
Method : DERIVED FROM SERUM APO A1 AND APO B VALUES

Sample Type : SERUM
Barcode : T3885340
Page : 7 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 3.83 mg/L
Reference Range :-
ADULT : <=3.0 MG/L
INTERPRETATION:
HIGH SENSITIVITY C-REACTIVE PROTEIN, WHEN USED IN CONJUNCTION WITH OTHER CLINICAL LABORATORY EVALUATION OF ACUTE
CORONARY SYNDROMES, MAY BE USEFUL AS AN INDEPENDENT MARKER OF PROGNOSIS FOR RECURRENT EVENTS, IN PATIENTS
WITH STABLE CORONARY DISEASE OR ACUTE CORONARY SYNDROMES. HSCRP LEVELS SHOULD NOT BE SUBSTITUTED FOR
ASSESSMENT OF TRADITIONAL CARDIOVASCULAR RISK FACTORS. PATIENTS WITH PERSISTENTLY UNEXPLAINED, MARKED
EVALUATION OF HSCRP AFTER REPEATED TESTING SHOULD BE EVALUATED FOR NON - CARDIOVASCULAR ETIOLOGIES
CLINICAL SIGNIFICANCE:
HSCRP MEASUREMENTS MAY BE USED AS AN INDEPENDENT RISK MARKER FOR THE IDENTIFICATION OF INDIVIDUALS AT RISK FOR
FUTURE CARDIOVASCULAR DISEASE. ELEVATED CRP VALUES MAY BE INDICATIVE OF PROGNOSIS OF INDIVIDUALS WITH ACUTE
CORONARY SYNDROMES, AND MAY BE USEFUL IN THE MANAGEMENT OF SUCH INDIVIDUALS.
SPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.
REFERENCES:
1. CHENILLOT O, HENNY J, STEINMEZ J, ET AL. HIGH SENSITIVITY C-REACTIVE PROTEIN: BIOLOGICAL VARIATIONS AND REFERENCE
LIMITS. CLIN CHEM LAB MED 2000;38:1003-11.
2. HIND CRH, PEPYS MB. THE ROLE OF SERUM C-REACTIVE PROTEIN MEASUREMENTS IN CLINICAL PRACTICE. INT MED
1984;5:112-51.
Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 56.4 mg/dl
Reference Range :-
ADULTS : < 30.0 MG/DL
INTERPRETATION:
DETERMINATION OF LPA MAY BE USEFUL TO GUIDE MANAGEMENT OF INDIVIDUALS WITH A FAMILY HISTORY OF CHD OR WITH
EXISTING DISEASE. THE LEVELS OF LPA IN THE BLOOD DEPENDS ON GENETIC FACTORS; THE RANGE OF VARIATION IN A
POPULATION IS RELATIVELY LARGE AND HENCE FOR DIAGNOSTIC PURPOSE, RESULTS SHOULD ALWAYS BE ASSESSED IN
CONJUNCTION WITH THE PATIENT’S MEDICAL HISTORY, CLINICAL EXAMINATION AND OTHER FINDINGS.
SPECIFICATIONS:
PRECISION: INTRA ASSAY (%CV): 3.4 %, INTER ASSAY (%CV): 2.0 %; SENSITIVITY: 0.002 GM/L
EXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:
COLLEGE OF AMERICAN PATHOLOGISTS: GENERAL CHEMISTRY AND TDM; CAP NUMBER: 7193855-01
KIT VALIDATION REFERENCES:
KOSCHINSKY ML, MARCOVINA SM. LIPOPROTEIN A: STRUCTURAL IMPLICATION FOR PATHOPHYSIOLOGY. INT J CLIN LAB RES, 1997;
27: 14-23.
Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

SERUM COPPER PHOTOMETRY 153 µg/dL
Reference Range :-
MALE : 63.5 - 150

FEMALE : 80 - 155
CLINICAL SIGNIFICANCE
COPPER IS AN IMPORTANT TRACE ELEMENT AND A COMPONENT OF NUMEROUS ENZYMES AND PROTEINS INVOLVED IN ENERGY
PRODUCTION, CONNECTIVE TISSUE FORMATION, MELANIN SYNTHESIS, IRON METABOLISM, DEVELOPMENT OF CENTRAL NERVOUS
SYSTEM, ANGIOGENESIS AS WELL AS AN ANTIOXIDANT.
DEFICIENCY CAN CAUSE - MALNOURISHMENT, CARDIOVASCULAR DISEASE, ANEMIA & NEUROPATHY. TOXICITY MAY BE MANIFESTED
AS ACUTE RENAL FAILURE, GASTROENTERITIS & CHRONIC LIVER DISEASE.
REFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY AND MOLECULAR
DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE: 948-952.
Method:- 3,5-DIBR-PAESA

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

SERUM ZINC PHOTOMETRY 136.53 µg/dL
Reference Range :-
52 - 286
CLINICAL SIGNIFICANCE
ZINC IS ONE OF THE ESSENTIAL TRACE ELEMENTS IN THE BODY. ITS METALLOENZYMES PLAY A KEY ROLE IN PROTEIN AND NUCLEIC
ACID SYNTHESIS, GENE EXPRESSION, WOUND HEALING, AS AN ANTIOXIDANT, ETC.
DEFICIENCY CAN CAUSE - POOR WOUND HEALING, GASTROENTERITIS, IMPAIRED SPERMATOGENESIS, ALZHEIMER’S DISEASE, ETC.
TOXICITY MAY BE MANIFESTED AS PANCREATITIS, GASTRIC ULCER, ANEMIA, PULMONARY FIBROSIS.
REFERENCE: CARL A. BURTIS, EDWARD R. ASHWOOD, DAVID E. BRUNS. TIETZ TEXTBOOK OF CLINICAL CHEMISTRY AND MOLECULAR
DIAGNOSTICS. CHAPTER 31.VITAMINS AND TRACE ELEMENTS. PAGE:960-965.
Method:- NITRO - PAPS

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

TESTOSTERONE C.L.I.A 9.34 ng/dL
Reference Range :-
Adult Male
21 - 49 Yrs : 164.94 - 753.38
50 - 89 Yrs : 86.49 - 788.22
Adult Female
Pre-Menopause : 12.09 - 59.46
Post-Menopause: < 7.00 - 48.93
Boys
2-10 Years : < 7.00 - 25.91
11 Years : < 7.00 - 341.53
12 Years : < 7.00 - 562.59
13 Years : 9.34 - 562.93
14 Years : 23.28 - 742.46
15 Years : 144.15 - 841.44
16-21 Years : 118.22 - 948.56
Girls
2-10 Years : < 7.00 - 108.30
11-15 Years : < 7.00 - 48.40
16-21 Years : 17.55 - 50.41
Clinical Significance:
Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males. Major causes of lowered
testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema, Hypopituitarism some types of
liver and kidney diseases and critical illness.
Specifications: Precision: Intra assay (%CV): 8.5 %, Inter assay (%CV): 12.6%; Sensitivity: 7 ng/dL.
External quality control program participation:

College of American pathologists: Ligand assay (special) survey; cap number: 7193855-01
Method:- FULLY AUTOMATED BIDIRECTIONALLY INTERFACED CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Labcode : 0507092053/UP172
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

IRON PHOTOMETRY 32 µg/dl

Reference Range :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 346 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 9.25 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES

Sample Type : SERUM
Barcode : T3885340
Page : 13 of 20
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

TOTAL CHOLESTEROL PHOTOMETRY 243 mg/dl < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 65 mg/dl 40-60
TRIGLYCERIDES PHOTOMETRY 98 mg/dl < 150
LDL CHOLESTEROL - DIRECT PHOTOMETRY 152 mg/dl < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 3.7 Ratio 3-5
LDL / HDL RATIO CALCULATED 2.3 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 19.6 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 177.8 mg/dl < 160
Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
TRIG - Enzymatic, End Point
LDL - Direct Measure
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - Derived from serum HDL and LDL Values
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
NHDL - Derived from serum Cholesterol and HDL values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500

VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

ALKALINE PHOSPHATASE PHOTOMETRY 118.4 U/L 45 - 129
BILIRUBIN -DIRECT PHOTOMETRY 0.21 mg/dl < 0.3
BILIRUBIN - TOTAL PHOTOMETRY 0.67 mg/dl 0.3-1.2
BILIRUBIN (INDIRECT) CALCULATED 0.46 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 16 U/l < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 52.6 U/l < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 57.3 U/l < 34
PROTEIN - TOTAL PHOTOMETRY 6.9 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.6 gm/dl 3.2-4.8
SERUM GLOBULIN PHOTOMETRY 2.3 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 2 Ratio 0.9 - 2
Method :
ALKP - Modified IFCC method
BILD - Vanadate Oxidation
BILT - Vanadate Oxidation
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - Modified IFCC method
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

OPP. ST ANTHONY SCHOOL COURT ROAD CIVIL LINES
REF. BY : DR AMIT SRIVASTAVA
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 117 ng/dl 60-200

TOTAL THYROXINE (T4) C.L.I.A 7 µg/dl 4.5-12
THYROID STIMULATING HORMONE (TSH) C.L.I.A 8.75 µIU/ml 0.3-5.5
Comments : IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION

Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 11.42 mg/dl 7 - 25
CREATININE - SERUM PHOTOMETRY 0.57 mg/dl 0.5-0.8
URIC ACID PHOTOMETRY 4.5 mg/dl 3.2 - 6.1
CALCIUM PHOTOMETRY 8.99 mg/dl 8.8-10.6
BUN / SR.CREATININE RATIO CALCULATED 20.04 Ratio 9:1-23:1
Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
URIC - Uricase / Peroxidase Method
CALC - ARSENAZO III METHOD, END POINT.
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES

Sample Type : SERUM
PROCESSED AT :
Thyrocare
Navi Mumbai-400 703

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 107 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.
Method:- CKD-EPI Creatinine Equation
~~ End of report ~~

Sample Type : SERUM
Labcode : 0507092053/UP172
CUSTOMER DETAILS
As declared in our data base
Name: MRS SAVITRI SINGH Age: 52Y Sex: F Customer Mobile No: 9169930001
Barcodes/Sample_Type : T3121856 (EDTA),T3885340 (SERUM)

Labcode : 0507091650,0507092053
Ref By : DR AMIT SRIVASTAVA
Sample_Type/Tests : EDTA:ELEMENTS 22 (TOXIC AND NUTRIENTS) , HBA , HEMOGRAM - 6
PART (DIFF)
SERUM:AAROGYAM 1.3
Sample Collected At : OPP. ST ANTHONY SCHOOL COURT ROAD CIVIL LINES BARABANKI,
UTTAR PRADESH - 225001
Amount Collected : Rs.1700/-(one thousand seven hundred only)
Thyrocare,D-37/1,MIDC,Turbhe,Navi Mumbai - 400703. | Phone:022 - 6712 3400 |www.thyrocare.com | info@thyrocare.com
Page : 19 of 20
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950851,8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 20 of 20

Savitri Singh Thyrocare

Uploaded by

Copyright:

Available Formats

Savitri Singh Thyrocare

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Savitri Singh Thyrocare

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Reference Range: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 05 Jul 2021 09:10

Sample Received on (SRT) : 06 Jul 2021 01:16

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

<= 60 years: <= 1.03 mg/L

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

25-OH VITAMIN D (TOTAL) C.L.I.A 12.63 ng/ml

Specifications: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

External quality control program participation:

Kit validation references:

Sample Collected on (SCT) : 05 Jul 2021 09:10

Sample Received on (SRT) : 06 Jul 2021 01:23

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 150 mg/dL

Sample Collected on (SCT) : 05 Jul 2021 09:10

Sample Received on (SRT) : 06 Jul 2021 01:23

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

ADULT : <=3.0 MG/L

SPECIFICATIONS: PRECISION: WITHIN RUN %CV HAS BEEN RECORDED <=5%.

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

ADULTS : < 30.0 MG/DL

EXTERNAL QUALITY CONTROL PROGRAM PARTICIPATION:

KIT VALIDATION REFERENCES:

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

MALE : 63.5 - 150

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

External quality control program participation:

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

IRON PHOTOMETRY 32 µg/dl

Sample Collected on (SCT) : 05 Jul 2021 09:10

Sample Received on (SRT) : 06 Jul 2021 01:23

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

Sample Collected on (SCT) : 05 Jul 2021 09:10

NAME : MRS SAVITRI SINGH (52Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE

TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 117 ng/dl 60-200

Comments : IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION